Free Trial

Extendicare (TSE:EXE) Sets New 1-Year High - What's Next?

Extendicare logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Extendicare hit a new 52-week high of C$29.47, trading at that level on volume of 88,760 shares and up from a prior close of C$28.81.
  • Analysts have been upgrading the stock — TD Securities moved to a Buy rating and raised its target to C$32, while CIBC, BMO and National Bank also lifted targets (consensus: Buy; average target: C$28.64).
  • Recent results showed EPS of C$0.29 on revenue of C$462.03 million, with a net margin of 5.82% and ROE of 47.65%; the company trades at a PE of 26.67, market cap ~C$2.8B and has a debt-to-equity ratio of 91.85.
  • Interested in Extendicare? Here are five stocks we like better.

Extendicare Inc. (TSE:EXE - Get Free Report) shares hit a new 52-week high on Thursday . The company traded as high as C$29.47 and last traded at C$29.47, with a volume of 88760 shares. The stock had previously closed at C$28.81.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the stock. National Bank Financial upped their price objective on shares of Extendicare from C$24.50 to C$29.00 and gave the stock an "outperform" rating in a report on Thursday, February 5th. TD Securities upgraded shares of Extendicare from a "hold" rating to a "buy" rating and upped their price objective for the stock from C$19.00 to C$32.00 in a report on Monday. Canadian Imperial Bank of Commerce upped their price objective on shares of Extendicare from C$22.00 to C$32.00 in a report on Thursday, April 2nd. Finally, BMO Capital Markets upped their price objective on shares of Extendicare from C$24.00 to C$30.00 in a report on Monday, March 2nd. One analyst has rated the stock with a Strong Buy rating and four have issued a Buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus target price of C$28.64.

View Our Latest Report on Extendicare

Extendicare Stock Up 3.0%

The company has a quick ratio of 0.98, a current ratio of 1.37 and a debt-to-equity ratio of 91.85. The company's fifty day moving average is C$25.65 and its 200-day moving average is C$21.39. The company has a market cap of C$2.80 billion, a PE ratio of 26.67 and a beta of 1.18.

Extendicare (TSE:EXE - Get Free Report) last issued its earnings results on Thursday, February 26th. The company reported C$0.29 earnings per share (EPS) for the quarter. Extendicare had a net margin of 5.82% and a return on equity of 47.65%. The company had revenue of C$462.03 million for the quarter. On average, analysts predict that Extendicare Inc. will post 0.6134729 EPS for the current year.

Extendicare Company Profile

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Extendicare Right Now?

Before you consider Extendicare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.

While Extendicare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines